Cargando…
PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database
BACKGROUND: Identify key biomarkers to improve the clinical prognosis of patients with advanced and metastatic clear cell renal cell carcinoma (ccRCC) remains an important research topic. Recently, ccRCC has been regarded as a metabolic disease. Pantothenate kinase-1 (PANK1) has been shown to play a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372198/ https://www.ncbi.nlm.nih.gov/pubmed/35966310 http://dx.doi.org/10.21037/tcr-22-1488 |
_version_ | 1784767327660670976 |
---|---|
author | Wang, Bin Liu, Bin Luo, Qing Sun, Ding Li, Hao Zhang, Jie Jin, Xinye Cheng, Xiaowei Niu, Jingxue Yuan, Qing Chen, Yizhi |
author_facet | Wang, Bin Liu, Bin Luo, Qing Sun, Ding Li, Hao Zhang, Jie Jin, Xinye Cheng, Xiaowei Niu, Jingxue Yuan, Qing Chen, Yizhi |
author_sort | Wang, Bin |
collection | PubMed |
description | BACKGROUND: Identify key biomarkers to improve the clinical prognosis of patients with advanced and metastatic clear cell renal cell carcinoma (ccRCC) remains an important research topic. Recently, ccRCC has been regarded as a metabolic disease. Pantothenate kinase-1 (PANK1) has been shown to play an important regulatory role in global metabolism and associates with the pathogenesis of hepatocellular carcinoma. Therefore, we aimed to investigate the role of PANK1 in the prognosis of ccRCC and in metabolism and immunity. METHODS: PANK1 messenger ribonucleic acid (RNA) expression patterns in ccRCC using The Cancer Genome Atlas (TCGA) database. The clinical prognostic significance of PANK1 in ccRCC and a Cox regression was performed to evaluate the clinical factors associated with prognosis with confounding factors adjusted. The signaling pathways related to PANK1 expression were identified by Gene Ontology (GO) investigation and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. The Tumor Immune Estimation Resource database was used to analyze the correlation between PANK1 and tumor-infiltrating immune cells. RESULTS: A total of 539 ccRCC patients and corresponding clinical samples and data from TCGA were included in this analysis. Significant differences were observed in PANK1 expression levels between tumor tissues and adjacent normal tissues in both TCGA-Kidney Renal Clear Cell Carcinoma cohort (4.40 vs. 2.94, P<0.001). PANK1 expression was found to be correlated with pathological stage, histological grade, age, sex, and clinical prognosis. Specifically, the low expression of PANK1 was found to be closely related to poor overall survival (OS), disease-specific survival (DSS), and the progression-free survival (PFS) in ccRCC patients. The receiver operating characteristic curve suggested that PANK1 could be a potential prognostic biomarker (area under the curve =0.880), and that the promoter methylation levels of PANK1 were correlated with clinical factors. Further, PANK1 expression was found to be associated with multiple immune cell types and correlated with the enrichment of these cells. Finally, we further investigated the role of PANK1 in tumor growth and mitochondrial metabolism using ccRCC cells. CONCLUSIONS: PANK1 correlates with ccRCC prognosis, tumor immune status and metabolism using the TCGA data. PANK1 might be a prognostic marker of clinical prognosis for ccRCC patients. |
format | Online Article Text |
id | pubmed-9372198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-93721982022-08-13 PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database Wang, Bin Liu, Bin Luo, Qing Sun, Ding Li, Hao Zhang, Jie Jin, Xinye Cheng, Xiaowei Niu, Jingxue Yuan, Qing Chen, Yizhi Transl Cancer Res Original Article BACKGROUND: Identify key biomarkers to improve the clinical prognosis of patients with advanced and metastatic clear cell renal cell carcinoma (ccRCC) remains an important research topic. Recently, ccRCC has been regarded as a metabolic disease. Pantothenate kinase-1 (PANK1) has been shown to play an important regulatory role in global metabolism and associates with the pathogenesis of hepatocellular carcinoma. Therefore, we aimed to investigate the role of PANK1 in the prognosis of ccRCC and in metabolism and immunity. METHODS: PANK1 messenger ribonucleic acid (RNA) expression patterns in ccRCC using The Cancer Genome Atlas (TCGA) database. The clinical prognostic significance of PANK1 in ccRCC and a Cox regression was performed to evaluate the clinical factors associated with prognosis with confounding factors adjusted. The signaling pathways related to PANK1 expression were identified by Gene Ontology (GO) investigation and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. The Tumor Immune Estimation Resource database was used to analyze the correlation between PANK1 and tumor-infiltrating immune cells. RESULTS: A total of 539 ccRCC patients and corresponding clinical samples and data from TCGA were included in this analysis. Significant differences were observed in PANK1 expression levels between tumor tissues and adjacent normal tissues in both TCGA-Kidney Renal Clear Cell Carcinoma cohort (4.40 vs. 2.94, P<0.001). PANK1 expression was found to be correlated with pathological stage, histological grade, age, sex, and clinical prognosis. Specifically, the low expression of PANK1 was found to be closely related to poor overall survival (OS), disease-specific survival (DSS), and the progression-free survival (PFS) in ccRCC patients. The receiver operating characteristic curve suggested that PANK1 could be a potential prognostic biomarker (area under the curve =0.880), and that the promoter methylation levels of PANK1 were correlated with clinical factors. Further, PANK1 expression was found to be associated with multiple immune cell types and correlated with the enrichment of these cells. Finally, we further investigated the role of PANK1 in tumor growth and mitochondrial metabolism using ccRCC cells. CONCLUSIONS: PANK1 correlates with ccRCC prognosis, tumor immune status and metabolism using the TCGA data. PANK1 might be a prognostic marker of clinical prognosis for ccRCC patients. AME Publishing Company 2022-07 /pmc/articles/PMC9372198/ /pubmed/35966310 http://dx.doi.org/10.21037/tcr-22-1488 Text en 2022 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Wang, Bin Liu, Bin Luo, Qing Sun, Ding Li, Hao Zhang, Jie Jin, Xinye Cheng, Xiaowei Niu, Jingxue Yuan, Qing Chen, Yizhi PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database |
title | PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database |
title_full | PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database |
title_fullStr | PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database |
title_full_unstemmed | PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database |
title_short | PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database |
title_sort | pank1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the tcga database |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372198/ https://www.ncbi.nlm.nih.gov/pubmed/35966310 http://dx.doi.org/10.21037/tcr-22-1488 |
work_keys_str_mv | AT wangbin pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase AT liubin pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase AT luoqing pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase AT sunding pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase AT lihao pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase AT zhangjie pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase AT jinxinye pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase AT chengxiaowei pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase AT niujingxue pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase AT yuanqing pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase AT chenyizhi pank1associateswithcancermetabolismandimmuneinfiltrationinclearcellrenalcellcarcinomaaretrospectiveprognosticstudybasedonthetcgadatabase |